| 660258 |
ONCOTARGETS AND THERAPY |
Circ-PITX1 Promotes the Progression of Non-Small Cell Lung Cancer Through Regulating the miR-1248/CCND2 Axis |
2021-03-01 |
10.2147/ott.s286820 |
Yue Qianyu, Xu Yanyan, Deng Xiaoli, Wang Shenglan, Qiu Jingman, Qian Baojiang, Zhang Yunhui |
| 660257 |
ONCOTARGETS AND THERAPY |
Global Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma |
2021-03-01 |
10.2147/ott.s282763 |
Zheng Yan, Wen Yibo, Cao Huixia, Gu Yue, Yan Lei, Wang Yanliang, Wang Limeng, Zhang Lina, Shao Fengmin |
| 660256 |
ONCOTARGETS AND THERAPY |
Biological Function of HYOU1 in Tumors and Other Diseases |
2021-03-01 |
10.2147/ott.s297332 |
Rao Shan, Oyang Linda, Liang Jiaxin, Yi Pin, Han Yaqian, Luo Xia, Xia Longzheng, Lin Jinguan, Tan Shiming, Hu Jiaqi, Wang Hui, Tang Lu, Pan Qing, Tang Yanyan, Zhou Yujuan, Liao Qianjin |
| 660255 |
ONCOTARGETS AND THERAPY |
Early Study of Tumor Abnormal Protein in Gastric Adenocarcinoma |
2021-03-01 |
10.2147/ott.s297413 |
Zhang Ming, Wang Xiaoyu, Wang Zhenghua |
| 660254 |
ONCOTARGETS AND THERAPY |
Prognostic Implications of the Complement Protein C1Q and Its Correlation with Immune Infiltrates in Osteosarcoma |
2021-03-01 |
10.2147/ott.s295063 |
Huang Hanji, Tan Manli, Zheng Li, Yan Guohua, Li Kanglu, Lu Dejie, Cui Xiaofei, He Si, Lei Danqing, Zhu Bo, Zhao Jinmin |
| 660253 |
ONCOTARGETS AND THERAPY |
High Expression of LINC01268 is Positively Associated with Hepatocellular Carcinoma Progression via Regulating MAP3K7 |
2021-03-01 |
10.2147/ott.s295814 |
Jin Xiuli, Fu Weixin, Li Dan, Wang Ningning, Chen Jiayu, Zeng Zilu, Guo Jiaqi, Liu Hao, Zhong Xinping, Peng Hu, Yu Xin, Sun Jing, Zhang Xinhe, Wang Xue, Xu Beibei, Lin Yingbo, Liu Jianping, Kutter Claudia, Li Yiling |
| 660252 |
ONCOTARGETS AND THERAPY |
Oral PI3K-δ,γ Inhibitor for the Management of People with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Narrative Review on Duvelisib |
2021-03-01 |
10.2147/ott.s189032 |
Shah Ankit, Barrientos Jacqueline |
| 660251 |
ONCOTARGETS AND THERAPY |
Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development |
2021-03-01 |
10.2147/ott.s242224 |
Gmeiner William H |
| 660250 |
ONCOTARGETS AND THERAPY |
Identification of Novel Alectinib-Resistant ALK Mutation G1202K with Sensitization to Lorlatinib: A Case Report and in silico Structural Modelling |
2021-03-01 |
10.2147/ott.s293901 |
Yang Ping, Cao Ran, Bao Hua, Wu Xue, Yang Lingling, Zhu Dongqin, Zhang Lu, Peng Liming, Cai Yuefei, Zhang Weijun, Shao Yang |
| 660249 |
ONCOTARGETS AND THERAPY |
Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC |
2021-03-01 |
10.2147/ott.s288936 |
Shao Huilin, Zhang Yue, Yan Jie, Ban Xinchao, Fan Xiaojie, Chang Xiaoyan, Lu Zhaohui, Wu Yan, Zong Liju, Mo Shengwei, Yu Shuangni, Chen Jie |
